Browsing by Author "Moreno, Marcela"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Estudio y manejo de nódulos tiroideos por médicos no especialistas. Consenso SOCHED
    (Sociedad Medica de Santiago, 2017) Tala, Hernán; Díaz, René; Domínguez, José; Sapunar, Jorge; Pineda, Pedro; Arroyo, Patricia; Barberán, Marcela; Cabané, Patricio; Cruz, Francisco; Gac, Patricio; Glasinovic, Andrea; González, Hernán; Grob, Francisca; Hidalgo, Maria; Jaimovich, Rodrigo; Lanas, Alejandra; Liberman, Claudio; Lobo, Maite; Madrid, Arturo; Moreno, Marcela; Mosso, Lorena; Munizaga, Fernando; Ortiz, Eugenia; Osorio, Fernando; Slater, Jeannie; Solar, Antonieta; Stehr, Carlos; Vásquez, Félix; Véliz, Jesús; Villaseca, Roberto; Wohllk, Nelson
    The thyroid nodule is a frequent cause of primary care consultation. The prevalence of a palpable thyroid nodule is approximately 4-7%, increasing up to 67% by the incidental detection of nodules on ultrasound. The vast majority are benign and asymptomatic, staying stable over time. The clinical importance of studying a thyroid nodule is to exclude thyroid cancer, which occurs in 5 to 10% of the nodules. The Board of SOCHED (Chilean Society of Endocrinology and Diabetes) asked the Thyroid Study Group to develop a consensus regarding the diagnostic management of the thyroid nodule in Chile, aimed at non-specialist physicians and adapted to the national reality. To this end, a multidisciplinary group of 31 experts was established among university academics, active researchers with publications on the subject and prominent members of scientific societies of endocrinology, head and neck surgery, pathology and radiology. A total of 14 questions were developed with key aspects for the diagnosis and subsequent referral of patients with thyroid nodules, which were addressed by the participants. In those areas where the evidence was insufficient or the national reality had to be considered, the consensus opinion of the experts was used through the Delphi methodology. The consensus was approved by the SOCHED board for publication.
  • Thumbnail Image
    Publication
    Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors
    (2025) Alcalá, Daniel; Acosta, Ana; Andreani, Sebastian; Andriessen, Anneke; Cárdenas, Hebert; Moreno, Marcela; Motola, Daniel; Riganti, Julia; Ollague, José; Lacouture, Mario; Toquica, Alejandra
    Background: Cancer-treatment-related cutaneous adverse events (cAEs) are common and may severely impact quality of life (QoL) and decrease treatment outcomes. The Latin American Cutaneous Oncology Management (LACOM) project provides clinical insights into cancer-treatment-related cAEs, offering tools for preventing and managing cAEs. Methods: LACOM I focuses on integrating education, prophylactic measures, and skincare in cancer treatment to improve treatment adherence, outcomes, and patients' and survivors' QoL. Results: The LACOM panel provides evidence and opinion-based best practice recommendations for oncology skincare programs to support all stakeholders in the Latin American healthcare setting (Argentina, Chili, Colombia, Ecuador, Panama, Peru, and Mexico) working with oncology patients throughout the entire continuum of care to achieve optimal outcomes, improving cancer patients and survivors' QoL. Oncology skincare programs comprise hygiene, moisturization, and sun protection with products that should be safe and help to minimize cAEs and improve skin conditions. Conclusions: Integrating education, general measures, and skincare programs into cancer treatment should encourage the adoption of a proactive role of skincare from the beginning of treatment and ongoing, supporting optimal outcomes and improving cancer patients' and survivors' QoL. J Drugs Dermatol. 2025;24(3):262-268. doi:10.36849/JDD.8565.

Implementado por OpenGeek Services